Search research articles
Contact Us
Filters
Showing results (171-180 of 249) with videos related to
Page
of 25
Sort By:
Plos One
|
December 4, 2018
Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patients
Monika Rau, Johannes Schmitt, Thomas Berg, et al.
Zeitschrift Fur Gastroenterologie
|
February 15, 2023
[Intersectoral management of patients with abnormal liver enzymes and non-alcoholic fatty liver disease (NAFLD)]
Andreas Teufel, Andreas Geier, Christoph Sarrazin, et al.
Journal of Clinical Medicine
|
April 9, 2024
Cardio-Hepatic Interaction in Cardiac Amyloidosis
Sandra Michaela Ihne-Schubert, Oliver Goetze, Felix Gerstendörfer, et al.
Endocrine Connections
|
January 11, 2022
Cardio-psycho-metabolic outcomes of bariatric surgery: design and baseline of the WAS trial
Ann-Cathrin Koschker, Bodo Warrings, Caroline Morbach, et al.
Cancers
|
April 23, 2022
Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World Analysis
Catherine Leyh, Ursula Ehmer, Daniel Roessler, et al.
Scandinavian Journal of Gastroenterology
|
October 2, 2018
Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study
Andreas Geier, Mareile Eichinger, Guido Stirnimann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 10, 2022
Final safety and efficacy results from a 106 real-world patients registry with an ascites-mobilizing pump
Guido Stirnimann, Thomas Berg, Laurent Spahr, et al.
Zeitschrift Fur Gastroenterologie
|
May 15, 2025
Evaluating Resmetirom Eligibility Among Patients with MASH: Insights from the German Steatotic Liver Disease-Registry
Eva Katharina Messer, David Petroff, Jörn Schattenberg, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
June 28, 2014
Downregulation of duodenal SLC transporters and activation of proinflammatory signaling constitute the early response to high altitude in humans
Kacper A Wojtal, Alexandra Cee, Silvia Lang, et al.
Journal of Cancer Research and Clinical Oncology
|
July 21, 2022
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study
Daniel Roessler, Osman Öcal, Alexander B Philipp, et al.
Page
of 25
Search research articles
Search
Showing results (171-180 of 249) with videos related to
Sort By:
Page
of 25
Plos One
|
December 4, 2018
Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patients
Monika Rau, Johannes Schmitt, Thomas Berg, et al.
Zeitschrift Fur Gastroenterologie
|
February 15, 2023
[Intersectoral management of patients with abnormal liver enzymes and non-alcoholic fatty liver disease (NAFLD)]
Andreas Teufel, Andreas Geier, Christoph Sarrazin, et al.
Journal of Clinical Medicine
|
April 9, 2024
Cardio-Hepatic Interaction in Cardiac Amyloidosis
Sandra Michaela Ihne-Schubert, Oliver Goetze, Felix Gerstendörfer, et al.
Endocrine Connections
|
January 11, 2022
Cardio-psycho-metabolic outcomes of bariatric surgery: design and baseline of the WAS trial
Ann-Cathrin Koschker, Bodo Warrings, Caroline Morbach, et al.
Cancers
|
April 23, 2022
Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World Analysis
Catherine Leyh, Ursula Ehmer, Daniel Roessler, et al.
Scandinavian Journal of Gastroenterology
|
October 2, 2018
Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study
Andreas Geier, Mareile Eichinger, Guido Stirnimann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 10, 2022
Final safety and efficacy results from a 106 real-world patients registry with an ascites-mobilizing pump
Guido Stirnimann, Thomas Berg, Laurent Spahr, et al.
Zeitschrift Fur Gastroenterologie
|
May 15, 2025
Evaluating Resmetirom Eligibility Among Patients with MASH: Insights from the German Steatotic Liver Disease-Registry
Eva Katharina Messer, David Petroff, Jörn Schattenberg, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
June 28, 2014
Downregulation of duodenal SLC transporters and activation of proinflammatory signaling constitute the early response to high altitude in humans
Kacper A Wojtal, Alexandra Cee, Silvia Lang, et al.
Journal of Cancer Research and Clinical Oncology
|
July 21, 2022
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study
Daniel Roessler, Osman Öcal, Alexander B Philipp, et al.
Page
of 25